The global extracorporeal CO2 removal devices market size is expected to be worth around US$ 121.64 million by 2030, according to a new report by Vision Research Reports.
The global extracorporeal CO2 removal devices market size was valued at US$ 84.80 million in 2020 and is anticipated to grow at a CAGR of 7.3% during forecast period 2021 to 2030.
|Market Size||USD 121.64 million by 2030|
|Growth Rate||CAGR of 7.3% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Segments Covered||Product, Application, Access, End use|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||Medtronic; Getinge AB; Xenios AG; Alung Technologies; ESTOR SpA; Medica SpA; Aferectica Srl|
Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).
An increasing number of regulatory product approvals for several extracorporeal removal devices during the COVID-19 pandemic helped various market players to increase their product sales. For instance, in April 2020, Alung Technologies received Emergency Use Authorization (EUA) from the U.S. FDA for Hemolung Respiratory Assist System (RAS) for the treatment of COVID-19.
By Product Analysis
The extracorporeal CO2 machines segment accounted for the largest revenue share of 52.3% in 2020. Technical simplification has caused the development and potential applications of extracorporeal CO2 extraction devices to progress rapidly, avoiding nearly some of the initial problems associated with ECMO.
The disposables segment is expected to grow at a significant CAGR of 4.87% over the forecast period. Disposables are used per procedures per patient basis in extracorporeal CO2 removal therapy. High consumption and demand for consumables in such procedures are predicted to augment the segment growth.
By Access Analysis
The venovenous segment accounted for the highest revenue share of 65.30% in 2020. In venovenous access, the blood is drawn from the central vein through a drainage cannula using a roller or centrifugal pump to produce flow across the gas exchange membrane. In recent years, a new generation of extracorporeal CO2 removal devices has been developed.
The arteriovenous segment is estimated to register the fastest CAGR over the forecast years. With arteriovenous extracorporeal CO2 removal devices, the blood flows from the femoral artery with the help of a gas exchanger and returns into the contralateral femoral vein.
By End-use Analysis
The hospitals segment captured the largest revenue share of over 47.36% in 2020. An increasing number of hospital admissions, especially the patients suffering from ARDS due to the recent outbreak of COVID-19, is predicted to boost the segment growth.Rising cases of COPD and ARDS are also anticipated to fuel the product demand in hospitals.
The Ambulatory Surgical Centers (ASCs) segment is projected to register significant CAGR from 2021 to 2030. This growth can be accredited to the rising cases of acute respiratory failure, especially in rural areas that have limited access to healthcare services.
By Application Analysis
The bridge to lung transplant segment accounted for the largest revenue share of more than 40% in 2020. Patients waiting for lung transplantation that develop life-threatening hypercarbia may benefit from extracorporeal CO2 removal devices by using them as a bridge to transplantation.
The rising focus of manufacturers, such as Alung Technologies and Xenios AG, on developing extracorporeal CO2 removal devices for bridge to lung transplantation is anticipated to spur the market growth during the forecast period.
By Regional Analysis
Asia Pacific is anticipated to register the largest CAGR of 8.24% during the forecast period. The presence of a large patient pool, rising awareness regarding acute respiratory failure, increasing government healthcare expenditure in developing countries, such as India and Japan, are predicted to accelerate the regional market growth.
A huge population base with low per capita income in the region leads to high demand for affordable treatment options. Thus, multinational companies are looking forward to investing in developing countries, such as China, anticipating regional market growth.
Early adoption of novel technologies and a large patient pool of ARDS and COPD are also anticipated to accelerate the regional market growth. In addition, increasing cases of chronic respiratory diseases are anticipated to create demand for extracorporeal CO2 removal devices.
The market in Europe is expected to expand at the second-fastest CAGR of over 7% during the forecast period. Increasing demand for healthcare devices coupled with the rising prevalence of chronic diseases, such as respiratory failure, is expected to drive the regional market.
Extracorporeal CO2 Machines
Acute Respiratory Distress Syndrome (ARDS)
Chronic Obstructive Pulmonary Disease (COPD)
Bridge to Lung Transplant
Ambulatory Surgical Centers
Middle East & Africa
The Extracorporeal CO2 Removal Devices market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Extracorporeal CO2 Removal Devices market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Extracorporeal CO2 Removal Devices market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Extracorporeal CO2 Removal Devices market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Extracorporeal CO2 Removal Devices market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Extracorporeal CO2 Removal Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Extracorporeal CO2 Removal Devices by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Extracorporeal CO2 Removal Devices market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Extracorporeal CO2 Removal Devices market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Extracorporeal CO2 Removal Devices market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Extracorporeal CO2 Removal Devices industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Extracorporeal CO2 Removal Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Extracorporeal CO2 Removal Devices market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Extracorporeal CO2 Removal Devices market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Extracorporeal CO2 Removal Devices market. These factors have benefited the growth of the global market for Extracorporeal CO2 Removal Devices. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Extracorporeal CO2 Removal Devices. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Extracorporeal CO2 Removal Devices are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Trauma Care Centers Market (By Facility Type: In-house, Standalone; By Trauma Type: Falls, Traffic-related Injuries; By Service Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Monkeypox Vaccine And Treatment Market (By Product: Vaccine, Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
AI in Oncology Market (By Treatment: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy; By Cancer Type; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Paracetamol IV Market (By Application: Surgical, Non-surgical; By Indication: Pyrexia, Pain; By End-use: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...